Lancet study suggests 9/11 firefighters may have higher risk of cancer
The Lancet has published a study that reports a “modest excess of cancer cases” in 9/11 New York City firefighters. The researchers caution that…
Oncology
FDA approves new melanoma drug
The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have the BRAF…
Single sigmoidoscopy screen reduces colorectal cancers
Undergoing a single screening sigmoidoscopy between ages 55 and 64 reduced the incidence of colorectal cancer according to a study of 34,272. Read more.
Smoking soon after waking may increase cancer risk
Smoking the first cigarette soon after waking is associated with a greater risk of head and neck cancer according to a study published by…
Evidence-based interventions for the prevention of bleeding in patients with cancer
Learn how you can help prevent bleeding in patients with cancer.
Mice study finds genetic link between lung cancer and emphysema
In a study of mice, scientists found that a gene associated with emphysema can also cause the development of lung cancer not related to…
Silent killer: Adenocarcinoma at the esophagogastric junction
Low survival rates, high mortality, and lack of public awareness make this cancer especially dangerous.
Evidence-based interventions for sleep-wake disturbances
Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society
FDA approves new treatment for metastatic melanoma
The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.
Persistent fatigue after breast cancer may speed aging
Researchers have found that persistent fatigue in breast cancer survivors may be caused by disruption in the autonomic system, and could make some patients…
Statins lower prostate cancer recurrence
Men with high-risk prostate cancer who take statin drugs while receiving radiation therapy are less likely to have their cancer return than patients who…
Evidence-based interventions for constipation in patients with cancer
Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Constipation is a common but often unrecognized…
Lancet study suggests 9/11 firefighters may have higher risk of cancer
The Lancet has published a study that reports a “modest excess of cancer cases” in 9/11 New York City firefighters. The researchers…
FDA approves new melanoma drug
The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have…
Single sigmoidoscopy screen reduces colorectal cancers
Undergoing a single screening sigmoidoscopy between ages 55 and 64 reduced the incidence of colorectal cancer according to a study of 34,272.…
Smoking soon after waking may increase cancer risk
Smoking the first cigarette soon after waking is associated with a greater risk of head and neck cancer according to a study…
Evidence-based interventions for the prevention of bleeding in patients with cancer
Learn how you can help prevent bleeding in patients with cancer.
Mice study finds genetic link between lung cancer and emphysema
In a study of mice, scientists found that a gene associated with emphysema can also cause the development of lung cancer not…
Silent killer: Adenocarcinoma at the esophagogastric junction
Low survival rates, high mortality, and lack of public awareness make this cancer especially dangerous.
Evidence-based interventions for sleep-wake disturbances
Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society
FDA approves new treatment for metastatic melanoma
The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.
Persistent fatigue after breast cancer may speed aging
Researchers have found that persistent fatigue in breast cancer survivors may be caused by disruption in the autonomic system, and could make…
Statins lower prostate cancer recurrence
Men with high-risk prostate cancer who take statin drugs while receiving radiation therapy are less likely to have their cancer return than…
Evidence-based interventions for constipation in patients with cancer
Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Constipation is a common but…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.